Xue Li

Xue Li

Auto-generated profile, based on publicly available information

Xue Li

Juxintang (Chengdu) Biotechnology Co. Ltd., Chengdu 641400, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2024 in Applied Physics Reviews
Verified
Journal Article
Closed access
PDF file
Shan LiuShan Liu
Shan Liu
XLXue Li
Xue Li
LGLi Gan
Li Gan
SLSutong Liu
Sutong Liu
HLHongzhi Luo
Hongzhi Luo
Chenzhong LiChenzhong Li
Chenzhong Li
Real-time health monitoring and precision treatment are important in the biomedical field. Researchers have focused on unique gadgets with peculiar functions, which have emerged from the merging of electronic components with biological systems. Because implantable bioelectronics can sense bodily information or elicit bodily reactions in living creatures from sites outside the body, they are becoming helpful and promising remedies for a variety of ailments. Carbon materials are more suitable than other materials for the manufacture of implantable medical electronics due to their excellent biocompatibility, fatigue resistance, and low specific gravity. Therefore, carbon materials can apply to a wide range of implantable drug delivery devices, biosensors, therapeutic stimulators, and energy storage and play irreplaceable roles in neurological, cardiovascular, gastrointestinal, and locomotor systems, among others. This review aims to offer researchers insight into carbon-based implantable bioelectronics in the biomedical field. Initially, various types of carbon materials were introduced. Subsequently, it delves into carbon-based implantable bioelectronics from four perspectives: implantable actuators, biosensors, drug delivery systems, and power supplies. Furthermore, we anticipate the future direction and potential applications of carbon-based implantable bioelectronics. Given the evolving field of nanotechnology and bioelectronics, we are optimistic that these devices will foster significant breakthroughs and innovations in the biomedical sector. Ultimately, this review aims to assist researchers in navigating the choices and directions of carbon-based implantable bioelectronics, thereby promoting the advancement of the biomedical field and contributing positively to the health and welfare of humankind.

24 January 2025 in Research
Verified
Journal Article
Open access
Shan LiuShan Liu
Shan Liu
JLJinkuan Liu
Jinkuan Liu
XLXue Li
Xue Li
XDXiaoxin Du
Xiaoxin Du
CYCheng Yin
Cheng Yin
Chenzhong LiChenzhong Li
Chenzhong Li
In 2001, Tang’s team discovered a unique type of luminogens with substantial enhanced fluorescence upon aggregation and introduced the concept of “aggregation-induced emission (AIE)”. Unlike conventional fluorescent materials, AIE luminogens (AIEgens) emit weak or no fluorescence in solution but become highly fluorescent in aggregated or solid states, due to a mechanism known as restriction of intramolecular motions (RIM). Initially considered a purely inorganic chemical phenomenon, AIE was later applied in biomedicine to improve the sensitivity of immunoassays. Subsequently, AIE has been extensively explored in various biomedical applications, especially in cell imaging. Early studies achieved nonspecific cell imaging using nontargeted AIEgens, and later, specific cellular imaging was realized through the design of targeted AIEgens. These advancements have enabled the visualization of various biomacromolecules and intracellular organelles, providing valuable insights into cellular microenvironments and statuses. Neurological disorders affect over 3 billion people worldwide, highlighting the urgent need for advanced diagnostic and therapeutic tools. AIEgens offer promising opportunities for imaging the central nervous system (CNS), including nerve cells, neural tissues, and blood vessels. This review focuses on the application of AIEgens in CNS imaging, exploring their roles in the diagnosis of various neurological diseases. We will discuss the evolution and conclude with an outlook on the future challenges and opportunities for AIEgens in clinical diagnostics and therapeutics of CNS disorders.

16 June 2023 in Virtual Reality & Intelligent Hardware
Verified
Journal Article
Open access
MYMin Yang
Min Yang
YHYong Han
Yong Han
CSChang Su
Chang Su
XLXue Li
Xue Li